Tag:
23andMe
Latest Headlines
Latest Headlines
Google's Brin allies with Pfizer and GSK in war on Parkinson's
Brin has put some serious dollars behind the R&D efforts, spending $132 million so far to fund programs through the Michael J. Fox Foundation and discovery work at pharma giants Pfizer and GlaxoSmithKline, Bloomberg reports.
Big prize in genomics might reside in bioinformatics
Even with a one-cent price tag, a single sequenced genome doesn't provide much value to those in pursuit of personalized treatments. Yet when thousands of genomes are sequenced, there's a...
23andMe eyes Big Pharma for future growth
Mountain View, CA-based 23andMe is moving beyond its roots as a provider of consumer genetic tests, reports Xconomy's Luke Timmerman. The company has been targeting a new customer base, drug
Social media multiply R&D input
Two recent research efforts highlight the potential of nontraditional computing advances on drug discovery and development. They illustrate alternative uses of social networks for data generation and
23andMe pockets $22M in new venture round
Despite some harsh recent criticism from government regulators on the usefulness and accuracy of its controversial consumer gene tests, the high-profile 23andMe scored a $22 million Series C round.
Scientists, lawyer 'unzip' their DNA for the world
Eleven British scientists and an American genetics lawyer have decided to "unzip" themselves in front of the whole world. They're part of what they call the Genomes Unzipped project, which aims to
FDA: Genetic tests are medical devices
The FDA will regulate certain types of diagnostic tests the same way the agency monitors medical devices. Genetic testing companies deCODE Genetics, Illumina, Knome, Navigenics, and 23andMe all
23andMe faces layoffs
It seems even Google-backed companies aren't immune to the economic crisis. Personal genetics company 23andMe has confirmed that its laying off an unspecified number of staffers. "We have reduced our
Markers thwart gene testers
Publicly available DNA tests from Navigenics and 23andMe intended to help consumers uncover genetic predispositions for diseases disagreed one-third of the time in tests on five people. The tests
Google hands $2.6M to 23andMe
It pays to be married to a Google co-founder. 23andMe, a genetics company started by Google co-founder's Sergey Brin's wife Anne Wojcicki ( photo ), has landed a $2.6 million investment from the
